Initially, we analysed the correlation between mRNA expression levels of RAD51 and its auxiliary protein RAD51AP1 with sensitivity to various anticancer drugs using the Cancer Therapeutics Response Portal (CTRP) database. The gene discussed is RAD51AP1; the disease is cancer.